Australia’s leading investment platform provider CommSec has just released data on the five most traded ASX shares on its platform from last week.
Once again, the usual suspects are populating the list this week, with buy now pay later (BNPL) and tech shares heavily featured.
Here’s the data:
Brainchip Holdings Ltd (ASX: BRN)
BrainChip was the most traded share on the CommSec platform last week by some distance. The ultra-low power high performance artificial intelligence technology provider’s shares accounted for a whopping 8.4% of trades on the platform. Approximately two-thirds of these trades came from buyers, helping to drive the BrainChip share price 30% higher over the period. Investors have been buying shares this month after it announced a potential program collaboration with NASA.
Zip Co Ltd (ASX: Z1P)
This BNPL provider was very popular with ASX investors again last week. Zip shares accounted for 3.4% of total trades made on the CommSec platform over the five days, with 61% coming from buyers. However, this wasn’t enough to stop the Zip share price from dropping notably lower. Concerns over PayPal’s entry into the BNPL market and a tech selloff weighed on its shares.
Afterpay Ltd (ASX: APT)
This payments company’s shares accounted for 2% of trades on the CommSec platform over the period. The buying and selling was largely even last week, with 47% of trades coming from the buy side. The Afterpay share price dropped 5.5% lower over the week due to the tech selloff.
BetaShares NASDAQ 100 ETF (ASX: NDQ)
This popular exchange traded fund (ETF) made the list for a second week in a row. The BetaShares NASDAQ 100 ETF was involved in 1.6% of trades on the CommSec platform last week. Once again, the majority of these trades came from the buy side, with 88% coming from buyers. Investors appear to believe the tech selloff on Wall Street has created a buying opportunity (I agree).
CSL Limited (ASX: CSL)
CSL has re-entered the top five with 1.5% of trades on the CommSec platform attributed to its shares. Last week the company announced plans to manufacture COVID-19 vaccines for Australia should one be successfully developed. Investors appeared to like this, with 72% of trades coming from buyers. The CSL share price edged higher over the five days.